"This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.
<h4>Background</h4>There are few data on the on post-treatment experiences of people who have been successfully treated for rifampicin-resistant (RR-)TB.<h4>Objective</h4>To describe the experiences and impact of RR-TB disease and therapy on post-treatment life of individuals...
Guardado en:
Autores principales: | Marian Loveday, Sindisiwe Hlangu, Lee-Megan Larkan, Helen Cox, Johnny Daniels, Erika Mohr-Holland, Jennifer Furin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f140b306ed6a4b65b33622e263aca742 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
por: Helen Cox, ProfPhD, et al.
Publicado: (2021) -
Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Anwar Sheed Khan, et al.
Publicado: (2021) -
Rifampicin-Induced Nephrotoxicity in a Tuberculosis Patient: Treatment Dilemma?
por: Antonio Grilo Novais, et al.
Publicado: (2021) -
Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.
por: Yukari C Manabe, et al.
Publicado: (2012) -
Author Correction: Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Anwar Sheed Khan, et al.
Publicado: (2021)